Discover Our ProductsWe offer a wide range of products for liquid biopsy and cancer screening based on the analysis of circulating EV and exosomes
We have a long-standing expertise and unique intellectual property related to the isolation and selective enrichment of tumor-originated extracellular vesicles (EVs) and exosomes from complex biofluids. To this purpose we develop and continuously implement our core line of proprietary reagents, kits and stand-alone solutions for cancer screening and liquid biopsy. This product line focuses on pre-analytical sample preparation and it is suitable for research use and clinical diagnostics.
Our sample type- and purpose-tailored exosomes/EVs isolation and pre-analytical tools provide solutions that shorten the translation of biomarker discovery and clinical research data into diagnostic assays. Our state-of-art pre-analytical solutions include:
Sample collection and stabilization
Selective EV/exosome Enrichment solutions with tunable selectivity for distinct EV types
Ready-to-use EV-RNA and DNA extraction kits
Overall, our EV Selective Enrichment portfolio is constantly improving according to emerging inputs and needs. For more info on the performance and state-of-development of our products, please contact: email@example.com
SeleCTEV™ DNA Enrichment Kits
SeleCTEV™ Enrichment kit allows the selective purification of tumor-derived DNA from tumor-enriched extracellular vesicles and exosomes from biofluids. The isolation is based on Exosomics’ proprietary peptide affinity method. Enables better downstream analytical performance.
USA: Exosomics’ SeleCTEV™ Enrichment Kits are provide for research use only (RUO).
Europe: Exosomics’s SeleCTEV™ Enrichment Kits are provided for research (RUO) and diagnostic (CE-IVD) purposes.
SoRTEV™ RNA Enrichment Kit
SoRTEV™ Enrichment kit allows the selective purification of tumor-derived RNA from tumor-enriched extracellular vesicles and exosomes from biofluids. The isolation is based on immuno-affinity binding to beads coated with Exosomics proprietary antibodies against exosome surface antigens.
ExoRefs are cancer-derived exosomes in a anhydrous format, with a defined mutation load. They have been specifically developed to standardize the performance of exosome-based pre-analytical and analytical diagnostic assays but they may also have broader applications in the liquid biopsy or exosome research fields (eg. in vivo studies). The ExoREFs are highly recommended as positive controls for SeleCTEV and SoRTEV kits, as stand alone or in association with any analytical platform (real time PCR, digital PCR or next generation sequencing).
LB-SeleCTEV™ EGFR Mutation Analysis
Exosomics SeleCTEV Liquid Biopsy Kit Line couples SeleCTEV DNA Enrichment Kit with analytical assays to overall improve the detection of clinically relevant targets.
Cancer rEVeal™ Kit Line is Exosomics patented immuno assay featuring double sandwich ELISA assay for quantification of specific subpopulation of circulating exosomes, based on the detection of pan-cancer metabolic markers expressed in EVs. The assay is based on a ready-to-use kit that can be performed in any research or clinical laboratory. This is an open platform and can be run on any bench plate-reader.